评估用于个性化医疗的新型生物标志物。
Evaluating Novel Biomarkers for Personalized Medicine.
作者信息
Drugan Tudor, Leucuța Daniel
机构信息
Department of Medical Informatics and Biostatistics, Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
出版信息
Diagnostics (Basel). 2024 Mar 11;14(6):587. doi: 10.3390/diagnostics14060587.
Abstract
Personalized medicine, sometimes referred to as precision medicine, is a paradigm shift in healthcare [...].
摘要
个性化医疗，有时也被称为精准医疗，是医疗保健领域的一种范式转变[……]
相似文献
1
Evaluating Novel Biomarkers for Personalized Medicine.评估用于个性化医疗的新型生物标志物。
Diagnostics (Basel). 2024 Mar 11;14(6):587. doi: 10.3390/diagnostics14060587.
2
[New directions in biomarker research, drug development and personalized medicine].[生物标志物研究、药物开发和个性化医疗的新方向]
Magy Onkol. 2013 Mar;57(1):5-10. Epub 2013 Feb 10.
3
Shifting to a Biomarker Paradigm Across Cancer Care.跨癌症护理转向生物标志物范式。
Clin J Oncol Nurs. 2020 Dec 1;24(6):633-634. doi: 10.1188/20.CJON.633-634.
4
The future for diabetic foot ulcer prevention: A paradigm shift from stratified healthcare towards personalized medicine.糖尿病足溃疡预防的未来：从分层医疗到个体化医学的范式转变。
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3234. doi: 10.1002/dmrr.3234. Epub 2020 Jan 16.
5
Personalized Regenerative Medicine.个性化再生医学
Acta Med Iran. 2017 Mar;55(3):144-149.
6
Critical Care and Personalized or Precision Medicine: Who needs whom?急危重症与个体化或精准医学：谁需要谁？
J Crit Care. 2018 Feb;43:401-405. doi: 10.1016/j.jcrc.2017.11.026. Epub 2017 Nov 16.
7
Value-Based Health Care Delivery, Preventive Medicine and the Medicalization of Public Health.基于价值的医疗服务、预防医学与公共卫生的医学化
Cureus. 2017 Mar 1;9(3):e1063. doi: 10.7759/cureus.1063.
8
Artificial intelligence and machine learning in precision medicine: A paradigm shift in big data analysis.人工智能和机器学习在精准医学中的应用：大数据分析的范式转变。
Prog Mol Biol Transl Sci. 2022;190(1):57-100. doi: 10.1016/bs.pmbts.2022.03.002. Epub 2022 Apr 8.
9
Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.深入探讨精准/个性化医学：破解生命的第三个字母——糖码，以及细胞的社会物质性。
OMICS. 2020 Feb;24(2):62-80. doi: 10.1089/omi.2019.0220. Epub 2020 Jan 28.
10
Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.生物标志物用于诊断、分层和治疗的验证现状与前景
Public Health. 2021 Jan;190:173-175. doi: 10.1016/j.puhe.2020.11.002. Epub 2020 Dec 9.
引用本文的文献
1
Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping.拉丁美洲癌症精准医学与健康公平：增进对政策制定和卫生系统塑造的理解
Int J Environ Res Public Health. 2025 Aug 5;22(8):1220. doi: 10.3390/ijerph22081220.
2
A supervised machine learning approach with feature selection for sex-specific biomarker prediction.一种用于性别特异性生物标志物预测的带特征选择的监督式机器学习方法。
NPJ Syst Biol Appl. 2025 Jul 1;11(1):69. doi: 10.1038/s41540-025-00523-z.
3
Large Language Models in Genomics-A Perspective on Personalized Medicine.基因组学中的大语言模型——个性化医疗视角
Bioengineering (Basel). 2025 Apr 23;12(5):440. doi: 10.3390/bioengineering12050440.
4
Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications.生物标志物驱动的骨转移治疗方法：从分子机制到临床应用
Biomedicines. 2025 May 10;13(5):1160. doi: 10.3390/biomedicines13051160.
5
Cancer treatment approaches within the frame of hyperthermia, drug delivery systems, and biosensors: concepts and future potentials.热疗、药物递送系统和生物传感器框架内的癌症治疗方法：概念与未来潜力。
RSC Adv. 2024 Dec 12;14(53):39297-39324. doi: 10.1039/d4ra06992g. eCollection 2024 Dec 10.
6
Postoperative Delirium and Neurocognitive Disorders: A Comprehensive Review of Pathophysiology, Risk Factors, and Management Strategies.术后谵妄与神经认知障碍：病理生理学、危险因素及管理策略的全面综述
Cureus. 2024 Sep 2;16(9):e68492. doi: 10.7759/cureus.68492. eCollection 2024 Sep.
7
Diagnostic and prognostic value of triglyceride glucose index: a comprehensive evaluation of meta-analysis.甘油三酯-葡萄糖指数的诊断和预后价值：荟萃分析的综合评价。
Cardiovasc Diabetol. 2024 Aug 23;23(1):310. doi: 10.1186/s12933-024-02392-y.
本文引用的文献
1
Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models.生物标志物与临床结局之间关联的建模：非线性联合模型介绍
Br J Clin Pharmacol. 2022 Feb;88(4):1452-1463. doi: 10.1111/bcp.15200. Epub 2022 Feb 3.
2
Introduction: Personalized medicine: what is it and what are the challenges?介绍：个性化医学：它是什么，以及面临哪些挑战？
Fertil Steril. 2018 Jun;109(6):944-945. doi: 10.1016/j.fertnstert.2018.04.027.
3
Introduction to the Symposium on Precision Medicine.精准医学研讨会介绍
Mayo Clin Proc. 2017 Jan;92(1):4-6. doi: 10.1016/j.mayocp.2016.10.027.
4
Editor-in-Chief editorial and introduction to 'Metabolomics and biomarkers' special issue.主编关于“代谢组学与生物标志物”特刊的社论及引言
Biomed Chromatogr. 2016 Jan;30(1):5-6. doi: 10.1002/bmc.3632.
Zotero 插件